372-31-6CCOC(=O)CC(=O)C(F)(F)FOCJKUQIPRNZDTK-UHFFFAOYSA-Nstructure in first source
372-31-6PFAS -> PFAS identified in REACH Regulation EC No. 1272/2008
PFAS -> Suspected persistent, mobile, toxic (PMT) PFAS or PFAS-like compounds
Liquid
Colorless liquid; [Alfa Aesar MSDS]
Warning
H226 (99.5%): Flammable liquid and vapor [Warning Flammable liquids]
P210, P233, P240, P241, P242, P243, P264, P270, P273, P280, P301+P317, P302+P352, P303+P361+P353, P321, P330, P332+P317, P362+P364, P370+P378, P403+P235, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 222 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Butanoic acid, 4,4,4-trifluoro-3-oxo-, ethyl ester is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Butanoic acid, 4,4,4-trifluoro-3-oxo-, ethyl ester are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
Status: Cease Manufacture Update: 11-01-2013 https://echa.europa.eu/registration-dossier/-/registered-dossier/12161
Ethyl 4,4,4-trifluoroacetoacetate: Does not have an individual approval but may be used under an appropriate group standard
Paint and Coating Manufacturing
Butanoic acid, 4,4,4-trifluoro-3-oxo-, ethyl ester: ACTIVE
UsesIntermediate for agro chemicals and pharmaceuticals (mefloquine). Product Data Sheet
UsesEthyl 4,4,4-trifluoroacetoacetate is used in the synthesis of fluorinated 2-thiouracil analogs as antithyroid agents.
UsesWidely used in the synthetic process of medicine, pesticides and organic intermediate.
Loading…
DTXSID5059905CHEMBL152164